City of Hope Medical Center
cityofhope.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
663
Active
322
Phase 3
8
Total enrollment
1,079,167
Pipeline matrix
Showing 40 of 274 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| trastuzumab | — | — | — | 9 | |||
| Trastuzumab Deruxtecan | — | — | — | — | — | 1 | |
| fluorouracil | — | — | 14 | ||||
| Bevacizumab | — | — | — | 7 | |||
| leucovorin calcium | — | — | 14 | ||||
| Mitomycin | — | — | — | 3 | |||
| irinotecan hydrochloride | — | — | 9 | ||||
| Extended Release Metformin Hydrochloride | — | — | — | — | — | 1 | |
| Cyclophosphamide | — | — | 58 | ||||
| Tacrolimus | — | — | — | — | 23 | ||
| Fludarabine | — | — | — | — | 20 | ||
| Nivolumab | — | — | — | — | 14 | ||
| Pembrolizumab | — | — | — | — | 19 | ||
| melphalan | — | — | 35 | ||||
| etoposide | — | — | 29 | ||||
| Rituximab | — | — | — | 18 | |||
| Venetoclax | — | — | — | — | 14 | ||
| Multi-peptide CMV-Modified Vaccinia Ankara Vaccine | — | — | — | 9 | |||
| Fludarabine Phosphate | — | — | — | 18 | |||
| carboplatin | — | — | — | — | 17 | ||
| Sirolimus | — | — | — | — | 13 | ||
| Leflunomide | — | — | — | 10 | |||
| Brentuximab Vedotin | — | — | — | — | 9 | ||
| Acalabrutinib | — | — | — | — | — | 5 | |
| Prednisone | — | — | — | — | 5 | ||
| paclitaxel | — | — | — | 16 | |||
| Mycophenolate Mofetil | — | — | — | 9 | |||
| oxaliplatin | — | — | — | — | 13 | ||
| Lenalidomide | — | — | — | — | 9 | ||
| Balstilimab | — | — | — | — | — | 5 | |
| Botensilimab | — | — | — | — | — | 5 | |
| Doxorubicin | — | — | — | — | 4 | ||
| methotrexate | — | — | — | 6 | |||
| Cytarabine | — | — | — | 10 | |||
| doxorubicin hydrochloride | — | — | — | — | 9 | ||
| Dexamethasone | — | — | — | — | 8 | ||
| Gemcitabine | — | — | — | — | 6 | ||
| Palifermin | — | — | — | — | 5 | ||
| Daratumumab | — | — | — | — | 5 | ||
| paclitaxel albumin-stabilized nanoparticle formulation | — | — | — | — | 5 |
234 more active programs hidden
Next readouts
- 2007-03-13
- 2011-03-16
- 2011-10-25
- 2013-08-01
- 2013-10-03
- 2013-12-30
- 2013-12-30
- 2016-07-13
- 2017-05-17
- 2017-12-04
Top conditions
- Breast Cancer41
- Acute Myeloid Leukemia28
- Myelodysplastic Syndrome27
- Malignant Solid Neoplasm26
- Lymphoma26
- Unspecified Adult Solid Tumor, Protocol Specific26
- Leukemia21
- Acute Lymphoblastic Leukemia18
Frequently asked questions about City of Hope Medical Center
- How many clinical trials does City of Hope Medical Center have on ClinicalTrials.gov?
- City of Hope Medical Center is listed as the lead sponsor on 663 clinical trials in ClinicalTrials.gov, 322 of which are currently active (recruiting, enrolling, or ongoing).
- How many of City of Hope Medical Center's trials are in Phase 3?
- 8 of City of Hope Medical Center's trials are in Phase 3, spread across 274 active drug programs.
- What therapeutic areas does City of Hope Medical Center focus on?
- City of Hope Medical Center's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Malignant Solid Neoplasm, Lymphoma.
- When are City of Hope Medical Center's next clinical trial readouts?
- City of Hope Medical Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders”, expected around 2007-03-13.